← back to search

Xiaozhong Wang

Nanchang University · CN
Area of research
Hematology · Molecular Biology
Research interest
Research focused on Microvesicles and microRNA, with related work in Immune system, Fibrinogen, Hemostasis. Notable publications include 'Exosomes: Novel Biomarkers for Clinical Diagnosis', 'Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond', and 'Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio'.
h-index
citations
2,260
works
48
NIH funding
primary concept
email

Recent publications

The role of intratumoral microbiome in the occurrence, proliferation, metastasis of colorectal cancer and its underlying therapeutic strategies
Ageing Research Reviews 2025cited by 15position: lastdoi
Bidirectional mendelian randomization and single-cell sequencing reveal T cell-mediated causal links between COPD and lung adenocarcinoma
International Journal of Surgery 2025cited by 6position: lastdoi
METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression
Cell Death and Disease 2025cited by 4position: lastdoi
Hexokinase 2-mediated histone H3K18la promotes PAI-1-dependent thrombosis in acute myeloid leukemia via tumor-endothelial crosstalk
Nature Communications 2025cited by 2position: lastdoi
Rheumatoid arthritis: emerging insights into molecular mechanisms and targeted immunotherapy
Clinical and Experimental Rheumatology 2025cited by 1position: lastdoi
Prognostic value of HSP27 in 28-day mortality in septic ICU patients: a retrospective cohort study
Frontiers in Medicine 2025cited by 1position: lastdoi
Machine learning-driven glycolytic subtyping and exosome-based PKM splicing modulation overcome drug resistance in hyper-glycolytic myeloid leukemia
npj Digital Medicine 2025cited by 1position: middledoi
Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases
Frontiers in Bioengineering and Biotechnology 2024cited by 33position: lastdoi
Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma
Cancer Medicine 2024cited by 17position: middledoi
High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5
Technology in Cancer Research & Treatment 2024cited by 5position: lastdoi
The role of tissue-derived extracellular vesicles in tumor microenvironment
Tissue and Cell 2024cited by 5position: lastdoi
A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma
Technology in Cancer Research & Treatment 2024cited by 4position: middledoi
The Daily Intake Levels of Copper, Selenium, and Zinc Are Associated with Osteoarthritis but Not with Rheumatoid Arthritis in a Cross-sectional Study
Biological Trace Element Research 2023cited by 28position: lastdoi
The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
Genes & Diseases 2023cited by 14position: lastdoi
Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia
Cancer Cell International 2023cited by 13position: lastdoi
Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia
Journal of Translational Medicine 2023cited by 9position: lastdoi
The association of serum uric acid with all-cause and cardiovascular mortality among adults with rheumatoid arthritis: a cohort study
Clinical and Experimental Rheumatology 2023cited by 7position: lastdoi
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia
Scientific Reports 2022cited by 29position: lastdoi
Expression and clinical significance of the m6A reader <i>YTHDF2</i> in peripheral blood mononuclear cells from rheumatoid arthritis patients
Journal of Immunotoxicology 2022cited by 20position: middledoi
A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
Lipids in Health and Disease 2022cited by 13position: lastdoi
Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study
Clinical and Experimental Rheumatology 2022cited by 13position: lastdoi
Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia
PeerJ 2022cited by 10position: lastdoi
RNA-binding proteins as drivers of AML and novel therapeutic targets
Leukemia & lymphoma/Leukemia and lymphoma 2022cited by 9position: lastdoi
m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis
Frontiers in Oncology 2021cited by 43position: lastdoi
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
Frontiers in Oncology 2021cited by 33position: middledoi
Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy
Frontiers in Genetics 2021cited by 6position: middledoi
Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia
Journal of Advanced Research 2020cited by 45position: middledoi
Correction of <i>Bcl</i><i>‐x</i> splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models
British Journal of Haematology 2020cited by 15position: middledoi
A Pooling Genome-Wide Association Study Identifies Susceptibility Loci and Signaling Pathways of Immune Thrombocytopenia in Chinese Han Population
International Journal of Genomics 2020cited by 5position: lastdoi
Profiles of volatile indole emitted by Escherichia coli based on CDI-MS
Scientific Reports 2019cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bo Huang · Chongqing University16 papers (2015–2025)Yanmei Xu · Hebei Medical University14 papers (2013–2023)Fangyi Yao · Nanchang University14 papers (2021–2025)Fangmin Zhong · Nanchang University14 papers (2021–2025)Lin Jin · University of Alabama at Birmingham11 papers (2015–2021)Weiming Yang · Nanchang University10 papers (2016–2025)Qinghua Min · Shanghai Jiao Tong University9 papers (2016–2021)Fan Sun · Nanchang University8 papers (2016–2020)Junyao Jiang · Nanchang University8 papers (2021–2025)Shuqi Li · University of Electronic Science and Technology of China8 papers (2016–2025)Jing Liu · First Affiliated Hospital of Guangzhou Medical University7 papers (2012–2023)Qiu‐Fang Gao · Nanchang University6 papers (2016–2018)Yuhuan Jiang · Nanchang University5 papers (2017–2019)Shuqi Li · The First Affiliated Hospital, Sun Yat-sen University5 papers (2018–2023)Hou‐Qun Ying · Guangzhou University of Chinese Medicine5 papers (2016–2019)Ying Cheng · Yunnan University5 papers (2022–2023)Mei‐Yong Li · Nanchang University5 papers (2021–2023)Shuqi Li · Ministry of Education4 papers (2020–2023)Jing Liu · Northwest A&F University4 papers (2017–2023)Bo Huang · Jiujiang University4 papers (2012–2025)